Humanity’s health is just another business in today’s world. For Blood and Money (2023) by financial journalist Nathan Vardi explores the development of a groundbreaking cancer drug, examining the roles played by scientists, pharmaceutical companies, and venture capitalists. It all began when a small team working in a California-based biotech startup discovered that a compound known as a BTK inhibitor showed promise against a severe form of leukemia. As patients experienced remarkable recoveries, the team realized the magnitude of their discovery – and investors swooped in.